Exelixis, Inc. Financials

Market Capitalization $9.75 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	22.02
Forward PE	20.08
Price to Sales TTM	$4.68
Price to Book MRQ	$4.29
Enterprise to Revenue	4.21
Enterprise to EBITDA	13.76

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	22.43%
Operating Margin	34.81%
Return on Assets TTM	12.81%
Return on Equity TTM	20.20%

Income Statement

Revenue TTM	$2,081,597,952
Revenue per Share TTM	$7.03
Quarterly Revenue Growth	14.30%
Gross Profit TTM	$2,003,593,984
EBITDA	$721,042,000
Net Income to Common TTM	$466,924,000
Diluted EPS TTM	$1.55
Quarterly Earnings Growth YoY	11232.70%

Balance Sheet

Total Cash MRQ	$1,189,160,960
Total Cash per Share MRQ	$4.16
Total Debt MRQ	$
Total Debt to Equity MRQ	8.55
Current Ratio MRQ	3.93
Book Value per Share MRQ	$7.96

Cash Flow

Operating Cash Flow TTM	$470,279,008
Levered Free Cash Flow TTM	$431,268,128

EXEL Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	285,579,008
Float Shares	238,455,626
Avg 10 Volume	3,038,670
Avg 30 Volume	None
Shares Short	10,450,134
Short Ratio	5.24
Short % of Shares	4.92%
% Held by Insiders	1.78%
% Held by Institutions	89.14%

Stock Price Summary

Beta	0.51
Fifty Two Week Low	$20.02
Fifty Two Week High	$37.59
Fifty Two Week Change	32.40%
Day 50 MA	$35.01
Day 200 MA	$27.19

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date